Kestra Financial

Kestra Medical Technologies is a commercial-stage medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease. The company's primary offering is the ASSURE Cardiac Recovery System, which features a next-generation wearable cardioverter defibrillator (WCD) designed to protect patients at risk of sudden cardiac arrest. The system integrates the wearable device with a mobile application and a cloud-based remote monitoring platform, CareStation, to provide continuous protection and clinical data to healthcare providers. Founded in 2014 and headquartered in Kirkland, Washington, Kestra went public on the NASDAQ in March 2025 under the symbol KMTS. The company aims to disrupt the WCD market by offering more intuitive and comfortable solutions for high-risk cardiac patients.